TRINSEO PLC (TSE)

IE0000QBK8U7 - Common Stock

3.88  -0.74 (-16.02%)

Fundamental Rating

1

TSE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 84 industry peers in the Chemicals industry. TSE may be in some trouble as it scores bad on both profitability and health. TSE has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

TSE had negative earnings in the past year.
TSE had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: TSE reported negative net income in multiple years.
In the past 5 years TSE always reported a positive cash flow from operatings.

1.2 Ratios

TSE has a worse Return On Assets (-15.69%) than 88.10% of its industry peers.
Industry RankSector Rank
ROA -15.69%
ROE N/A
ROIC N/A
ROA(3y)-8.42%
ROA(5y)-4.33%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

TSE has a worse Gross Margin (5.10%) than 86.90% of its industry peers.
TSE's Gross Margin has declined in the last couple of years.
TSE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-30.83%
GM growth 5Y-19.48%

1

2. Health

2.1 Basic Checks

TSE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TSE has more shares outstanding
The number of shares outstanding for TSE has been reduced compared to 5 years ago.
TSE has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.06, we must say that TSE is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of TSE (1.06) is worse than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.06
ROIC/WACCN/A
WACC6.3%

2.3 Liquidity

A Current Ratio of 1.65 indicates that TSE should not have too much problems paying its short term obligations.
TSE has a worse Current ratio (1.65) than 67.86% of its industry peers.
A Quick Ratio of 1.03 indicates that TSE should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.03, TSE is doing worse than 72.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.03

3

3. Growth

3.1 Past

TSE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -41.02%.
TSE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.98%.
Measured over the past years, TSE shows a decrease in Revenue. The Revenue has been decreasing by -4.48% on average per year.
EPS 1Y (TTM)-41.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-57.28%
Revenue 1Y (TTM)-25.98%
Revenue growth 3Y10.22%
Revenue growth 5Y-4.48%
Sales Q2Q%-1.29%

3.2 Future

The Earnings Per Share is expected to grow by 29.52% on average over the next years. This is a very strong growth
Based on estimates for the next years, TSE will show a small growth in Revenue. The Revenue will grow by 2.52% on average per year.
EPS Next Y2.02%
EPS Next 2Y24.35%
EPS Next 3Y24.93%
EPS Next 5Y29.52%
Revenue Next Year-3.12%
Revenue Next 2Y0.79%
Revenue Next 3Y2.52%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

TSE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year TSE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TSE is valued a bit more expensive than the industry average as 71.43% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.54

4.3 Compensation for Growth

TSE's earnings are expected to grow with 24.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.35%
EPS Next 3Y24.93%

1

5. Dividend

5.1 Amount

TSE has a yearly dividend return of 0.94%, which is pretty low.
Compared to an average industry Dividend Yield of 2.87, TSE has a dividend in line with its industry peers.
With a Dividend Yield of 0.94, TSE pays less dividend than the S&P500 average, which is at 2.24.
Industry RankSector Rank
Dividend Yield 0.94%

5.2 History

The dividend of TSE decreases each year by -20.01%.
TSE has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-20.01%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of TSE are negative and hence is the payout ratio. TSE will probably not be able to sustain this dividend level.
DP-0.38%
EPS Next 2Y24.35%
EPS Next 3Y24.93%

TRINSEO PLC

NYSE:TSE (11/7/2024, 4:15:00 PM)

3.88

-0.74 (-16.02%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap137.20M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.94%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.69%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 5.1%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.65
Quick Ratio 1.03
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-41.02%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y2.02%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-25.98%
Revenue growth 3Y10.22%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y